US › Healthcare

Nano X Imaging Ltd (NNOX)

US · Healthcare · Medical Devices

$0.45-7.78%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$4.2M

Revenue YoY

+36.7%

Net profit

$-55.5M

EPS

$-0.79

EPS estimate

$-0.12

Net margin

-1,335.1%

EPS came in at -0.79 against a street estimate of -0.12 — a miss of 558.3%.

Key statistics

Market cap

$40.1M

Forward P/E

0.0

P/B

0.76

Book value

$1.03

EPS (TTM)

$-1.72

52-week high

$4.71

52-week low

$0.50

50-day MA

$0.80

200-day MA

$1.78

Beta

1.26

Analyst view

Analysts rate Nano X Imaging Ltd a buy (2 buy, 1 hold, 0 sell out of 3) with an average price target of $4.13.

Shareholding

Insiders

7.18%

Institutions

12.40%

Largest institutional holders

Fund	Stake
UBS Group AG	2.09%
ARK Investment Management LLC	1.14%
Marshall Wace Asset Management Ltd	1.10%
Morgan Stanley - Brokerage Accounts	0.93%
BlackRock Inc	0.84%
AQR Capital Management LLC	0.79%
Bank of America Corp	0.65%
The Goldman Sachs Group Inc	0.49%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Nano X Imaging Ltd — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-19.